
Were You Diagnosed with Cancer After Using Chemical Hair Straighteners?
Over 4,000 women have filed lawsuits against major manufacturers[1]. NIH research links hair relaxers to uterine cancer, ovarian cancer, and other serious health conditions[2].
If you regularly used chemical hair relaxers or straighteners and were later diagnosed with cancer or reproductive issues, you may be entitled to significant compensation.
No Win, No Fee • Free Consultation • Confidential
Thousands of women across the United States have filed lawsuits against major hair care manufacturers, alleging that chemical hair relaxers and straighteners caused them to develop serious health conditions, including uterine cancer, ovarian cancer, and uterine fibroids.
The lawsuits claim that manufacturers like L'Oréal, Revlon, and others knew—or should have known—that these products contained dangerous chemicals but failed to adequately warn consumers about the cancer risks.
A landmark study by the National Institutes of Health tracked nearly 34,000 women over 11 years and found that women who used hair straighteners more than 4 times per year had more than double the risk of developing uterine cancer compared to those who never used these products.
Read NIH StudyWhy these conditions? The endocrine-disrupting chemicals (EDCs) in hair relaxers interfere with the body's natural hormone regulation. Because the scalp is highly permeable and the products are often heated, these chemicals are readily absorbed into the bloodstream, affecting reproductive organs and increasing cancer risk over time.
While no global settlement has been reached as of 2025, attorneys estimate potential compensation based on similar mass tort cases:
$100,000 - $1,500,000+
Uterine cancer, ovarian cancer, or other cancer diagnoses with significant medical needs
$50,000 - $300,000
Uterine fibroids, endometriosis, or other reproductive health conditions
Important: These are estimates based on similar mass tort litigation. Actual compensation will depend on individual case factors, trial outcomes, and potential settlement negotiations. No guarantee of results.
No Win, No Fee
Our network attorneys only get paid if you win your case. There is zero financial risk to getting your case evaluated.
Chemical hair relaxers have been primarily marketed to and used by Black women and girls. Research shows that Black women are significantly more likely to use these products—and to use them from a young age and for extended periods.
This means Black women have borne a disproportionate health burden from these dangerous products. The NIH Sister Study found that while the increased cancer risk applied to all frequent users, the impact on Black women's health has been particularly severe due to higher usage rates within this community.
For decades, manufacturers profited from products they knew or should have known posed serious health risks. This litigation seeks to hold them accountable for failing to warn consumers.
By taking legal action, victims are helping protect future generations of women and girls from these dangerous products and forcing industry-wide changes.
If you or a loved one has suffered from cancer or reproductive health issues after using hair relaxers, you deserve justice and compensation. Don't let manufacturers who put profits over safety escape responsibility.
All federal hair relaxer lawsuits have been consolidated into Multi-District Litigation (MDL 3060) in the U.S. District Court for the Northern District of Illinois under Judge Mary M. Rowland.
With over 4,000 cases already filed and bellwether trials approaching, now is the time to have your case evaluated. Early filers may have advantages in the litigation process, and statute of limitations deadlines vary by state.
The information on this page is based on peer-reviewed research and authoritative legal sources:
NIH Sister Study (2022)
NIH News ReleaseJournal of the National Cancer Institute
Full Research Article on PubMed (Chang et al., 2022)MDL 3060 Court Information
U.S. District Court, Northern District of IllinoisAdditional Research
Environmental Health Perspectives, Carcinogenesis Journal, American Journal of Epidemiology
This page is for informational purposes only and does not constitute legal or medical advice. Consult with a qualified attorney for case-specific guidance.
Don't wait. Statute of limitations deadlines apply. Find out if you qualify for compensation.
No Win, No Fee • Confidential • No Obligation